iqvia semaglutide tirzepatide prescriptions us q3 2024 GLP-1 Antagonists Increase Plan Drug Spend Outlook for obesity in 2025:

Several mechanisms may contribute to the positive effects of GLP1RAs in preventing HF and influencing the outcomes for patients with either HFpEF or HFrEF

Some patients benefit from alternating between treatment periods and maintenance phases, while others do best with continuous therapy

0.5mg 2x/week (flat) 2 injections/week P/T Ratio: ~1.8 Use Case: Post-goal maintenance Create Your Custom Semaglutide Microdosing Protocol These pre-built schedules represent common approaches, but optimal dosing varies by individual

Trial #4 Compared tirzepatide with people on metformin, and/or sulfonylureas and/or SGLT-2s with insulin Glargine on individuals with high cardiovascular (heart and blood vessels disease) risk